|
Home | Medical-Newswire.Com:
|
(EMAILWIRE.COM, July 11, 2011 ) Minneapolis, MN -- Pharmaceutical stocks continue to be hot.
At Mega Stock Picks, we are regularly right on when it comes to pharma stocks. Those who have been following us a while may recall KERX (Keryx Biopharmaceuticals), a pick that made gains of 1,000% several times over (from .18 to over $6) within one year.
And, just last week we featured MRNA (Marina Biotech, Inc.), another Nasdaq biotech. The day following our alert, MRNA jumped up 50 percent on huge volume.
We are currently featuring ARWR (Arrowhead Research Corp.). ARWR closed Friday in a flurry a flurry of activity. It jumped up to .5899 (up nearly .09 from our alert price) in the trading session's final minutes on huge volume before closing down.
The spike in activity is an indicator that we could be seeing something big. Possibly as a high as a dollar which would make ARWR a double. Perhaps higher than that in the weeks to follow.
ARWR is at a nice entry point currently. It's only a couple pennies off our alert price plus activity is picking up and it's not far off its 52-week low. With ARWR, it's not a matter of 'if' but 'when' it will see substatial gains.
For those looking for large pharma companies to watch, there's Pfizer, Inc. (NYSE: PFE) and Johnson and Johnson (NYSE: JNJ) and Keryx Biopharmaceuticals (Nasdaq: KERX). JNJ and PFE were down slightly on Friday while KERX saw modest gains.
Remember to visit us at www.megastockpicks.com. While there, be sure to sign up to our free e-newsletter.
About:
Mega Stock Picks is an investor relations site that provides free e-newsletters and stock alerts from its web site, www.megastockpicks.com. The company covers all sectors of the market from undervalued penny stocks to big-board bottom bouncers.
Disclaimer:
Mega Stock Picks is not a registered investment advisor. Investors are responsible for doing their own research and obtaining professional investment advice. Mega Stock Picks does not guarantee the accurateness of information in its communications. Investors should read the full disclaimer at www.megastockpicks.com before investing in any stock featured by the site.
Mega Stock Picks
Editor
612-638-8760
info@megastockpicks.com 
Source: EmailWire.com
|
|
|
|
